EPISODE · Jun 15, 2023 · 39 MIN
263: Biogen's messy board, Laronde's data problem, & the downside of a boom
from The Readout Loud · host STAT
Our colleague Allison DeAngelis joins us to share her reporting on how the handsomely funded Laronde Therapeutics, billed as “Moderna 2.0,” ran into behind-the-scenes problems with its scientific data. We also discuss how Biogen's boardroom scandal has roiled a company that was supposed to be entering a new era.
Embed this episode
NOW PLAYING
263: Biogen's messy board, Laronde's data problem, & the downside of a boom
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.